These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


106 related items for PubMed ID: 8057401

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Successful use of the two-tube approach for the treatment of phenobarbital poisoning without hemodialysis.
    Tanikawa A, Seki S, Yasuda T, Hasegawa E.
    Am J Emerg Med; 2019 Sep; 37(9):1809.e1-1809.e3. PubMed ID: 31257124
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Pharmacokinetics of amitriptyline influenced by oral charcoal and urine pH.
    Kärkkäinen S, Neuvonen PJ.
    Int J Clin Pharmacol Ther Toxicol; 1986 Jun; 24(6):326-32. PubMed ID: 3015809
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Decreased phenobarbital absorption with charcoal administration for chronic renal failure.
    Tanaka C, Yagi H, Sakamoto M, Koyama Y, Ohmura T, Ohtani H, Sawada Y.
    Ann Pharmacother; 2004 Jan; 38(1):73-6. PubMed ID: 14742799
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effect of oral activated charcoal on propranolol pharmacokinetics following intravenous administration to rabbits.
    al-Meshal MA, el-Sayed YM, al-Angary AA, al-Dardiri MM.
    J Clin Pharm Ther; 1993 Feb; 18(1):39-44. PubMed ID: 8473358
    [Abstract] [Full Text] [Related]

  • 14. Pharmacokinetics of theophylline and phenobarbital during peritoneal dialysis compared with intestinal dialysis in rats.
    Arimori K, Hashimoto Y, Nakano M.
    Chem Pharm Bull (Tokyo); 1990 Nov; 38(11):3177-9. PubMed ID: 2085904
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Randomized study of the treatment of phenobarbital overdose with repeated doses of activated charcoal.
    Pond SM, Olson KR, Osterloh JD, Tong TG.
    JAMA; 1984 Jun 15; 251(23):3104-8. PubMed ID: 6726981
    [Abstract] [Full Text] [Related]

  • 18. Pharmacokinetics of phenobarbital during certain enhanced elimination modalities to evaluate their clinical efficacy in management of drug overdose.
    Mohammed Ebid AH, Abdel-Rahman HM.
    Ther Drug Monit; 2001 Jun 15; 23(3):209-16. PubMed ID: 11360027
    [Abstract] [Full Text] [Related]

  • 19. Investigating the enteroenteric recirculation of apixaban, a factor Xa inhibitor: administration of activated charcoal to bile duct-cannulated rats and dogs receiving an intravenous dose and use of drug transporter knockout rats.
    Zhang D, Frost CE, He K, Rodrigues AD, Wang X, Wang L, Goosen TC, Humphreys WG.
    Drug Metab Dispos; 2013 Apr 15; 41(4):906-15. PubMed ID: 23386703
    [Abstract] [Full Text] [Related]

  • 20. Surface characterization of activated charcoal by X-ray photoelectron spectroscopy (XPS): correlation with phenobarbital adsorption data.
    Burke GM, Wurster DE, Berg MJ, Veng-Pedersen P, Schottelius DD.
    Pharm Res; 1992 Jan 15; 9(1):126-30. PubMed ID: 1589397
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.